Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma

BACKGROUND: Asthma is a disease with high cost for the National Health Service. Two of the most recent LABA/ICS combinations for persistent bronchial asthma are Beclomethasone dipropionate/Formoterol (B/F) delivered via the Nexthaler device and Fluticasone furoate/Vilanterol (F/V) delivered via the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dal Negro, Roberto W., Distante, Chiara, Bonadiman, Luca, Turco, Paola, Iannazzo, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893834/
https://www.ncbi.nlm.nih.gov/pubmed/27275384
http://dx.doi.org/10.1186/s40248-016-0055-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893834/
https://www.ncbi.nlm.nih.gov/pubmed/27275384
http://dx.doi.org/10.1186/s40248-016-0055-2

Ejemplares similares